Who are Exicure, Inc.'s main suppliers?

Exicure, Inc. (XCUR) key suppliers include: HITRON, MIRTO-CO-LTD, RMS0718-CO-LTD, SANGSANGIN-INVESTMENT-SECURITIES-CO-LTD, SHIN-CHANG-PARTNERS. View the full supplier network at chainsifter.com/chain/XCUR.

Who are Exicure, Inc.'s major customers?

Exicure, Inc. (XCUR) key customers include: FLASHPOINT-THERAPEUTICS-INC, GPCR-THERAPEUTICS-INC, CAPITAL-RESOURCES, CBI-USA-INC, DELAWARE-GENERAL-CORPORATION and 8 more. View the full customer network at chainsifter.com/chain/XCUR.

What sector is Exicure, Inc. in?

Exicure, Inc. (XCUR) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Exicure, Inc. Supplier List (XCUR): 5 Verified Suppliers

5Suppliers

13Customers

3Debt Items

0Related Chains

Source-Backed Evidence Depth

Exicure, Inc. (XCUR) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

22Total relationships

1Distinct source URLs

11High confidence

0.755Average confidence

2026-09-14Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Exicure, Inc. Suppliers

Ticker	Name	Confidence	Evidence
HITRON	HITRON	90%	Company agreed to sell and issue to HiTron 2,900,000 additional shares of Common Stock
MIRTO-CO-LTD	MIRTO-CO-LTD	90%	Company agreed to issue and sell to MIRTO 87,808 shares of our Common Stock
RMS0718-CO-LTD	RMS0718-CO-LTD	90%	Company agreed to issue and sell to each of the purchasers 145,454 shares at a purchase price of $5.50 per share
SANGSANGIN-INVESTMENT-SECURITIES-CO-LTD	SANGSANGIN-INVESTMENT-SECURITIES-CO-LTD	90%	Company agreed to issue and sell to SangSang 433,332 shares of the Company's Common Stock
SHIN-CHANG-PARTNERS	SHIN-CHANG-PARTNERS	90%	Company agreed to issue and sell to each of the purchasers 145,454 shares at a purchase price of $5.50 per share

Exicure, Inc. Customers

Ticker	Name	Confidence	Evidence
FLASHPOINT-THERAPEUTICS-INC	FLASHPOINT-THERAPEUTICS-INC	90%	Company entered into an asset purchase agreement with Flashpoint Therapeutics, Inc. to sell its historical biotechnology intellectual property and other assets
GPCR-THERAPEUTICS-INC	GPCR-THERAPEUTICS-INC	80%	Company acquired from GPCR all of the issued and outstanding equity securities of its then-subsidiary, GPCR Therapeutics USA Inc.
CAPITAL-RESOURCES	CAPITAL-RESOURCES	62%	. The effective tax rate for the year ended December 31, 2024 of 11.4% was attributable to the fact the Company was subject to the IRC Section 174 regulations requiring companies to capitalize certai…
CBI-USA-INC	CBI-USA-INC	62%	ubject us to additional risks and uncertainties, including increased costs and the increased possibility of legal proceedings and regulatory inquiries, sanctions or investigations. Management identif…
DELAWARE-GENERAL-CORPORATION	DELAWARE-GENERAL-CORPORATION	62%	ubject us to additional risks and uncertainties, including increased costs and the increased possibility of legal proceedings and regulatory inquiries, sanctions or investigations. Management identif…
DGP-CO-LTD	DGP-CO-LTD	62%	ubject us to additional risks and uncertainties, including increased costs and the increased possibility of legal proceedings and regulatory inquiries, sanctions or investigations. Management identif…
DIRECTORS-EXICURE-INC	DIRECTORS-EXICURE-INC	62%	agement, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion. 36 Table of Contents Critical Audit Matter …
DREN-BIO-MANAGEMENT-INC	DREN-BIO-MANAGEMENT-INC	62%	5 ) ( 253 ) Property and equipment, net $ 306 $ 26 Depreciation and amortization expense was $ 242 and $ 28 , for the years ended December 31, 2025 and 2024, respectively. During the year ended Decem…
DREN-BRIO-INC	DREN-BRIO-INC	62%	5 ) ( 253 ) Property and equipment, net $ 306 $ 26 Depreciation and amortization expense was $ 242 and $ 28 , for the years ended December 31, 2025 and 2024, respectively. During the year ended Decem…
EXICURE-HITRON-INC	EXICURE-HITRON-INC	62%	5 ) ( 253 ) Property and equipment, net $ 306 $ 26 Depreciation and amortization expense was $ 242 and $ 28 , for the years ended December 31, 2025 and 2024, respectively. During the year ended Decem…
GPCR-THERAPEUTICS-USA-INC	GPCR-THERAPEUTICS-USA-INC	62%	agement, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion. 36 Table of Contents Critical Audit Matter …
SECURITIES-INVESTOR-PROTECTION-CORP	SECURITIES-INVESTOR-PROTECTION-CORP	62%	f these instruments. The Company records short-term investments at their estimated fair value based on quoted market prices for identical or similar instruments. Investment in Convertible Notes Recei…
YOOSOO-CO-LTD	YOOSOO-CO-LTD	62%	5 ) ( 253 ) Property and equipment, net $ 306 $ 26 Depreciation and amortization expense was $ 242 and $ 28 , for the years ended December 31, 2025 and 2024, respectively. During the year ended Decem…

Exicure, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
XCUR-DEBT-13646	Warrants outstanding: 10022	90%	xbrl warrant detail from xbrl 2025-12-31.
XCUR-DEBT-13647	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2024-12-31.
XCUR-DEBT	Debt stack $1.0M	90%	Market cache reports total debt of $1.0M.

Exicure, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Exicure, Inc..

Exicure, Inc. Ownership

Holder	Name	Confidence	Evidence
XCUR-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC	VANGUARD CAPITAL MANAGEMENT LLC	90%	13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 19 tracked holders.

Exicure, Inc. Extended Supply Chain Network

No secondary connectionsNo correlated companies found through shared supply chain relationships.

Exicure, Inc. Supply Chain